Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.69 |
| ▸ | THRB | P10828 | 2/20 | 0.62 |
| ▸ | PKM | P14618 | 8/20 | 0.54 |
| ▸ | MEN1 | O00255 | 3/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.54 |
| ▸ | POLB | P06746 | 3/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24876204 | 0.88 | LMNA (0.56) | LMNATHRBPKMMEN1KMT2A | |
| SCHEMBL30211038 | 0.88 | LMNA (0.56) | LMNATHRBPKMMEN1KMT2A | |
| SCHEMBL24876014 | 0.84 | MEN1 (0.62) | LMNATHRBPKMMEN1KMT2A | |
| SCHEMBL24876753 | 0.82 | LMNA (1.00) | LMNATHRBPKMMEN1KMT2A | |
| SCHEMBL24876355 | 0.80 | MEN1 (0.63) | LMNATHRBPKMMEN1KMT2A | |
| SCHEMBL24876007 | 0.79 | LMNA (0.80) | LMNATHRBPKMMEN1KMT2A | |
| SCHEMBL24876242 | 0.79 | LMNA (0.80) | LMNATHRBPKMMEN1KMT2A | |
| SCHEMBL24876339 | 0.79 | LMNA (0.65) | LMNATHRBPKMMEN1KMT2A | |
| SCHEMBL31679978 | 0.79 | LMNA (0.65) | LMNATHRBPKMMEN1KMT2A | |
| SCHEMBL31679867 | 0.79 | LMNA (0.75) | LMNATHRBPKMMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4367103-B1 | INHIBITORS OF ALPHA-HEMOLYSIN OF STAPHYLOCOCCUS AUREUS | HELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH (DE) | 2025-09-03 | — | — | EP | disclosed |